about
Strength and specificity of the CMBA screening platform for bioactive molecules discoveryNew potent dual inhibitors of CK2 and Pim kinases: discovery and structural insightsAntitumor activity of pyridocarbazole and benzopyridoindole derivatives that inhibit protein kinase CK2Expanding the chemical diversity of CK2 inhibitors.Salicylaldehyde derivatives as new protein kinase CK2 inhibitors.Benzo[e]pyridoindoles, novel inhibitors of the aurora kinases.Antitumoral activity of allosteric inhibitors of protein kinase CK2.Azaindole derivatives are inhibitors of microtubule dynamics, with anti-cancer and anti-angiogenic activities.[Phenotypic screens or one stone to kill two birds: discover the target and its pharmacological regulator].Improving detection of rare biological events in high-throughput screens.A new chemical inhibitor of angiogenesis and tumorigenesis that targets the VEGF signaling pathway upstream of RasAcacetin and chrysin, two polyphenolic compounds, alleviate telomeric position effect in human cells.Synthesis and biological evaluation of thiophene and benzo[b]thiophene analogs of combretastatin A-4 and isocombretastatin A-4: A comparison between the linkage positions of the 3,4,5-trimethoxystyrene unit.Inhibition of p-aminobenzoate and folate syntheses in plants and apicomplexan parasites by natural product rubreserine.Single assay-wide variance experimental (SAVE) design for high-throughput screening.Functional characterization of cell-free expressed Kv1.3 channel using a voltage-sensitive fluorescent dye.Screening for biologically annotated drugs that trigger triacylglycerol accumulation in the diatom Phaeodactylum.Novel synthetic pharmacophores inducing a stabilization of cellular microtubules.Control-Plate Regression (CPR) Normalization for High-Throughput Screens with Many Active Features.Specific Targeting of Plant and Apicomplexa Parasite Tubulin through Differential Screening Using In Silico and Assay-Based ApproachesParthenolide inhibits tubulin carboxypeptidase activityMiniaturization and validation of a sensitive multiparametric cell-based assay for the concomitant detection of microtubule-destabilizing and microtubule-stabilizing agentsFörster Resonance Energy Transfer Based Biosensor for Targeting the hNTH1-YB1 Interface as a Potential Anticancer Drug TargetChimeric Protein-Protein Interface Inhibitors Allow Efficient Inhibition of Type III Secretion Machinery and Pseudomonas aeruginosa VirulenceHigh-Content Screening Identifies New Inhibitors of Connexin 43 Gap Junctions
P50
Q27014820-8DEC566D-F90C-4657-B6FC-BCB08738E6ADQ27660594-540D26C4-E031-4E6E-A138-14AE567A3DECQ27666125-0324945A-D32B-4E9B-AF4A-61568C9E9CA3Q33344802-4E4BCAD7-BBB9-40BD-9B88-6B971EC71AF9Q33357101-9D6F303A-181C-4F83-9C3B-06EC31E02E47Q33409814-D415B9E5-5245-4BC6-AE57-C5F92DE006CCQ34106499-EA038796-E396-4D80-AAA2-C308E8E61EA2Q34419792-B5A3BD6E-8B45-4285-915C-CBBC63FF0BBAQ35023854-4F4C2344-2DD1-4480-A229-5826BDCCC471Q35238899-041D15D6-8587-45FF-9CD9-E11F45B66986Q35572415-B75982FB-B350-4E14-8CEF-982811A0293FQ37138708-38902E5D-0055-410D-9C25-B2EA76B0CD2CQ38817093-0AD46BFC-1587-4ACF-95DB-B4FF8D8D6A15Q42109446-48B3CDFA-453C-4AC6-A478-D2CCA8494BEFQ47848670-13924400-1DF3-4DFA-8E59-15C6AEC171D8Q49791839-0137E598-2AB0-4A68-88D1-C5F0C245C7F2Q51147639-40E0ABA7-3941-49CE-BD71-1C8CC2101A1DQ52979855-588E9AFF-685E-4AF5-9010-3BE348CB27DEQ54389509-892AB263-ED4A-4D6B-9CE9-13AA2BB7AB70Q58052689-2B8BEE77-E34F-4C68-ABFF-610A16FCE823Q80099860-4970B76C-9BC9-401E-97AE-E10571D1E621Q83917993-6B1F6068-CD32-4080-B0AC-77168C80C11AQ89996069-2F0FFAFF-5F98-4F4B-8FB4-6386F8146397Q90126192-0E4B6B79-103F-4AC6-92C2-74E83E4475ADQ91956477-F7902DD4-8676-427A-98D7-FAAA17AE4392
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-0999-7751
@en
name
Caroline Barette
@ast
Caroline Barette
@en
Caroline Barette
@es
Caroline Barette
@nl
type
label
Caroline Barette
@ast
Caroline Barette
@en
Caroline Barette
@es
Caroline Barette
@nl
prefLabel
Caroline Barette
@ast
Caroline Barette
@en
Caroline Barette
@es
Caroline Barette
@nl
P106
P108
P21
P31
P496
0000-0003-0999-7751